2-Methyl-AP-237 2-MAP CAS: 98608-61-8

CAS NO: 98608-61-8
Our products are for experimental research only
2-Methyl-AP-237 2-MAP
Chemical Name: 1-Butanone, 1-[2-methyl-4-(3-phenyl-2-propen-1-yl)-1-piperazinyl]-

Molecular Formula: C18H26N2O
Formula Weight: 286.41
CAS No.: 98608-61-8
Description Review
Description
Our products are for experimental research only


2-Methyl-AP-237 2-MAP CAS: 98608-61-8 is a psychoactive drug that is used as a substitute for opioids. It has been developed as an alternative to traditional opioids like morphine and hydrocodone. It is available as a white crystalline powder and is classified as a novel psychoactive substance (NPS).

Chemical Information

Chemical name: 1-(2-Methylphenyl)-4-(N-phenylpropionamido)piperidine

Molecular formula: C21H28N2O

Formula weight: 324.46 g/mol

CAS No.: 98608-61-8

Top 10 keywords from Google and Synonyms

  1. Opioid substitute
  2. Novel psychoactive substance
  3. Synthetic opioid
  4. 2-MAP
  5. Opioid receptor agonist
  6. Analgesic
  7. Designer drug
  8. Dopamine uptake inhibitor
  9. Research chemical
  10. Synthetic benzimidazole

Synonyms:

  • 2-Methyl-AP237
  • Piperidin-4-yl 2-methylphenyl(N-phenylpropionamide)
  • 1-(2-Methylphenyl)-4-[(phenylacetyl)amino]piperidine

Health Benefits of this Product

2-Methyl-AP-237 2-MAP is primarily used as a substitute for opioids. It can be used as an analgesic to provide pain relief. Other potential health benefits of this drug include:

  1. Relaxation: 2-MAP can help promote relaxation and reduce stress levels.

  2. Improved mood: 2-MAP can help boost mood and improve feelings of well-being.

  3. Appetite suppression: 2-MAP can help suppress appetite, which can be useful for weight loss.

Potential Effects

2-Methyl-AP-237 2-MAP is a synthetic opioid that acts as an opioid receptor agonist. It produces effects similar to those of traditional opioids like morphine and hydrocodone. Some of the potential effects of 2-MAP include:

  1. Pain relief: 2-MAP can provide pain relief and help reduce the intensity of pain.

  2. Euphoria: 2-MAP can produce feelings of euphoria, which can be pleasurable for some people.

  3. Sedation: 2-MAP can produce sedative effects, which can result in drowsiness and a feeling of relaxation.

Product Mechanism

2-Methyl-AP-237 2-MAP binds to the mu-opioid receptor in the brain and nervous system. This binding results in the activation of pain-relieving pathways, which can provide relief from pain. In addition, 2-MAP can increase dopamine release, which can produce feelings of pleasure and euphoria.

Safety

The long-term safety of 2-Methyl-AP-237 2-MAP is not well understood, as it is a relatively new drug. However, there have been reports of adverse effects associated with its use. It is important to use this drug only under medical supervision and to follow dosing guidelines carefully.

Side Effects

The potential side effects of 2-Methyl-AP-237 2-MAP include:

  1. Nausea and vomiting
  2. Drowsiness
  3. Dizziness
  4. Headaches
  5. Constipation
  6. Respiratory depression
  7. Potential for addiction and dependence

Dosing Information

The recommended dose of 2-Methyl-AP-237 2-MAP varies depending on the individual's age, weight, and health status. It is important to use this drug only under medical supervision and to follow dosing guidelines carefully.

Conclusion

2-Methyl-AP-237 2-MAP is a synthetic opioid that acts as an opioid receptor agonist. It is primarily used as a substitute for traditional opioids and can provide pain relief. However, its long-term safety is not well understood, and it can produce adverse effects such as drowsiness, constipation, and respiratory depression. It is important to use this drug only under medical supervision and to follow dosing guidelines carefully to prevent potential health risks.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code